1. Home
  2. MDWD vs LESL Comparison

MDWD vs LESL Comparison

Compare MDWD & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • LESL
  • Stock Information
  • Founded
  • MDWD 2000
  • LESL 1963
  • Country
  • MDWD Israel
  • LESL United States
  • Employees
  • MDWD N/A
  • LESL N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • LESL Diversified Commercial Services
  • Sector
  • MDWD Health Care
  • LESL Miscellaneous
  • Exchange
  • MDWD Nasdaq
  • LESL Nasdaq
  • Market Cap
  • MDWD 184.8M
  • LESL 177.9M
  • IPO Year
  • MDWD 2014
  • LESL 2020
  • Fundamental
  • Price
  • MDWD $18.23
  • LESL $0.79
  • Analyst Decision
  • MDWD Strong Buy
  • LESL Hold
  • Analyst Count
  • MDWD 2
  • LESL 11
  • Target Price
  • MDWD $32.00
  • LESL $2.70
  • AVG Volume (30 Days)
  • MDWD 65.1K
  • LESL 9.7M
  • Earning Date
  • MDWD 03-19-2025
  • LESL 05-07-2025
  • Dividend Yield
  • MDWD N/A
  • LESL N/A
  • EPS Growth
  • MDWD N/A
  • LESL N/A
  • EPS
  • MDWD N/A
  • LESL N/A
  • Revenue
  • MDWD $19,720,000.00
  • LESL $1,331,389,000.00
  • Revenue This Year
  • MDWD $10.15
  • LESL $2.85
  • Revenue Next Year
  • MDWD $25.62
  • LESL $3.00
  • P/E Ratio
  • MDWD N/A
  • LESL N/A
  • Revenue Growth
  • MDWD N/A
  • LESL N/A
  • 52 Week Low
  • MDWD $12.78
  • LESL $0.76
  • 52 Week High
  • MDWD $24.00
  • LESL $7.70
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 55.16
  • LESL 21.46
  • Support Level
  • MDWD $16.00
  • LESL $0.91
  • Resistance Level
  • MDWD $18.29
  • LESL $1.05
  • Average True Range (ATR)
  • MDWD 1.00
  • LESL 0.11
  • MACD
  • MDWD 0.16
  • LESL -0.00
  • Stochastic Oscillator
  • MDWD 75.24
  • LESL 4.33

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.

Share on Social Networks: